IDAP, the IFPMA’s vision of innovation development and access pathways

The International Federation of Pharmaceutical Manufacturers and Associations proposed the IDAP (Innovation Development and Access Pathway) framework to streamline and, as far as possible, harmonise pathways for ensuring rapid authorisation and access to innovative medicines and vaccines, taking into account the specific characteristics of different countries.

The proposal of a Critical Medicines Act

The Critical Medicines Act proposed by the European Commission aims to overcome supply issues and shortages of medicinal products by mean of the activation of Strategic Projects, new procurement requirements and improved international partnerships

The Clean Industrial Deal and the Omnibus package on simplification

The European Commission published the Clean Industrial Deal on 26 February 2025, detailing the strategy that should support the final transition to the new models based on decarbonisation, electrification, innovation and reindustrialisation of the European Union. The first two Omnibus packages of measures aimed to lower energy prices, simplify procedures for companies and improve the InvestEU regulation were also released and will now undergo examination by the EU Parliament and Council